Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
Sponsor: Novartis Pharmaceuticals
Summary
This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.
Official title: A Phase II, Single Arm, Multicenter Open Label Trial to Determine the Efficacy and Safety of Tisagenlecleucel (CTL019) in Adult Patients With Refractory or Relapsed Follicular Lymphoma
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
98
Start Date
2018-11-12
Completion Date
2025-05-28
Last Updated
2026-06-16
Healthy Volunteers
No
Conditions
Interventions
tisagenlecleucel
Tisagenlecleucel is single infusion.
Locations (30)
City of Hope National Medical Center
Duarte, California, United States
UCSF Medical Center
San Francisco, California, United States
H Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Uni of Chi Medi Ctr Hema and Onco
Chicago, Illinois, United States
Univ of Kansas Hosp and Med Ctr
Kansas City, Kansas, United States
Michigan Med University of Michigan
Ann Arbor, Michigan, United States
Oregon Health Sciences University
Portland, Oregon, United States
University of Pennsylvania Clinical
Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center
Houston, Texas, United States
Novartis Investigative Site
Camperdown, New South Wales, Australia
Novartis Investigative Site
Melbourne, Victoria, Australia
Novartis Investigative Site
Herston, Australia
Novartis Investigative Site
Linz, Austria
Novartis Investigative Site
Ghent, Belgium
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Pierre-Bénite, France
Novartis Investigative Site
Munich, Bavaria, Germany
Novartis Investigative Site
Cologne, North Rhine-Westphalia, Germany
Novartis Investigative Site
Ulm, Germany
Novartis Investigative Site
Bologna, BO, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Sapporo, Hokkaido, Japan
Novartis Investigative Site
Sendai, Miyagi, Japan
Novartis Investigative Site
Fukuoka, Japan
Novartis Investigative Site
Amsterdam, North Holland, Netherlands
Novartis Investigative Site
Oslo, Norway
Novartis Investigative Site
Madrid, Spain
Novartis Investigative Site
Seville, Spain
Novartis Investigative Site
Birmingham, West Midlands, United Kingdom
Novartis Investigative Site
London, United Kingdom